News & Perspective

Dec 22, 2008

Dec 22, 2008

EU panel supports innovative pandemic, seasonal flu vaccines

(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.

Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.

Dec 16, 2008

Dec 16, 2008

Treatment comes first in HHS antiviral guidance

Editor's note: This story was revised Dec 17 to include an item that was mistakenly left out of the list of five main recommendations on antiviral use in a pandemic.

Nov 07, 2008

Nov 07, 2008

GAO: Obama should address health preparedness, food safety

(CIDRAP News) – The Government Accountability Office (GAO) has listed public health emergency preparedness and food safety as two of 13 "urgent issues" that will need attention from President-elect Barack Obama and the new Congress next year.

Oct 21, 2008

Oct 21, 2008

Group urges next administration to reform public health

(CIDRAP News) – Drawing on the expertise of more than 150 health experts, Trust for America's Health (TFAH), a nonprofit health advocacy group in Washington, DC, today released a report designed to help the next president and Congress reform the public health system to improve the nation's health and emergency preparedness.

Oct 03, 2008

Oct 03, 2008

Plant cancellation shows problems in flu vaccine business

(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.

Jun 17, 2008

Jun 17, 2008

Australia approves CSL's H5N1 vaccine

(CIDRAP News) – Australian authorities have approved an H5N1 avian influenza vaccine made by the Australian-based pharmaceutical company CSL Limited, giving the country a home-grown defensive tool if the virus evolves into a pandemic strain.

Jun 16, 2008

Jun 16, 2008

Sanofi to give WHO 60 million doses of H5N1 vaccine

(CIDRAP News) – Sanofi Pasteur pledged today to give 60 million doses of H5N1 influenza vaccine over 3 years to the World Health Organization (WHO) for a planned stockpile to help poor countries in the event of an influenza pandemic.

Jun 03, 2008

Jun 03, 2008

HHS offers pandemic guidance on masks, antivirals

(CIDRAP News) – Proposed pandemic preparedness guidance released by the federal government today recommends that people wear face masks if they have to go into crowds during an influenza pandemic and says critical infrastructure businesses should consider stockpiling antiviral drugs, among various other suggestions.

May 19, 2008

May 19, 2008

EU approves its first prepandemic H5N1 vaccine

(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.

Apr 29, 2008

Apr 29, 2008

HHS adds H5N1 clade 2.2 vaccine to stockpile

(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»